|
Dose Intensity Rates (DSI) in percentage
|
|---|
|
GEM Group (n = 9)
|
CIS/GEM Group (n = 21)
|
|---|
| | |
CIS
|
GEM
|
|---|
|
Cycles
|
Median
|
IQR
|
Cycles
|
Median
|
IQR
|
Median
|
IQR
|
|---|
|
C1
|
100
|
(91.7–100)
|
C1
|
100
|
(100–100)
|
100
|
(100–100)
|
|
C2
|
100
|
(95–100)
|
C2
|
100
|
(100–100)
|
100
|
(100–100)
|
|
C3
|
100
|
(90.9–100)
|
C3
|
100
|
(70–100)
|
100
|
(76.4–100)
|
|
C4
|
100
|
(86.7–100)
|
C4
|
80
|
(50–100)
|
100
|
(77.5–100)
|
|
C5
|
100
|
(95–100)
|
C5
|
80
|
(50–100)
|
100
|
(70–100)
|
|
C6
|
100
|
(88.9–100)
|
C6
|
80
|
(25–100)
|
94.1
|
(70–100)
|
| | | |
C7
|
50
|
(0–100)
|
88.9
|
(56.3–100)
|
| | | |
C8
|
50
|
(0–90)
|
75
|
(50–100)
|
|
Overall DSI
|
100
|
(91–100)
| |
100
|
(50–100)
|
100
|
(75–100)
|
- Abbreviations: GEM gemcitabine, CIS cisplatin, IQR interquartile range, C cycles
